Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (Vero Cell)
Clinical trial NCT04993365 · COMPLETED
Trial details
- NCT number
- NCT04993365
- Sponsor
- Sinovac Research and Development Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-05
- Primary completion
- 2022-07-14
- Enrollment
- 520
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.